Zhejiang Medicine Statistics

Total Valuation

SHA:600216 has a market cap or net worth of CNY 13.23 billion. The enterprise value is 11.72 billion.

Market Cap	13.23B
Enterprise Value	11.72B

Important Dates

The last earnings date was Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	Jul 10, 2024

Share Statistics

SHA:600216 has 961.64 million shares outstanding. The number of shares has increased by 0.46% in one year.

Current Share Class	961.64M
Shares Outstanding	961.64M
Shares Change (YoY)	+0.46%
Shares Change (QoQ)	+1.22%
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	5.82%
Float	582.82M

Valuation Ratios

The trailing PE ratio is 11.37 and the forward PE ratio is 10.28.

PE Ratio	11.37
Forward PE	10.28
PS Ratio	1.41
PB Ratio	1.22
P/TBV Ratio	1.33
P/FCF Ratio	24.77
P/OCF Ratio	10.82
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.19, with an EV/FCF ratio of 21.94.

EV / Earnings	10.10
EV / Sales	1.25
EV / EBITDA	5.19
EV / EBIT	7.77
EV / FCF	21.94

Financial Position

The company has a current ratio of 2.56, with a Debt / Equity ratio of 0.07.

Current Ratio	2.56
Quick Ratio	1.67
Debt / Equity	0.07
Debt / EBITDA	0.33
Debt / FCF	1.40
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 9.78% and return on invested capital (ROIC) is 8.40%.

Return on Equity (ROE)	9.78%
Return on Assets (ROA)	7.09%
Return on Invested Capital (ROIC)	8.40%
Return on Capital Employed (ROCE)	13.44%
Revenue Per Employee	1.51M
Profits Per Employee	186,368
Employee Count	6,227
Asset Turnover	0.71
Inventory Turnover	2.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.80% in the last 52 weeks. The beta is 0.63, so SHA:600216's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+31.80%
50-Day Moving Average	13.49
200-Day Moving Average	15.13
Relative Strength Index (RSI)	55.75
Average Volume (20 Days)	22,709,897

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:600216 had revenue of CNY 9.38 billion and earned 1.16 billion in profits. Earnings per share was 1.21.

Revenue	9.38B
Gross Profit	3.97B
Operating Income	1.51B
Pretax Income	1.21B
Net Income	1.16B
EBITDA	2.23B
EBIT	1.51B
Earnings Per Share (EPS)	1.21

Full Income Statement

Balance Sheet

The company has 2.26 billion in cash and 748.43 million in debt, giving a net cash position of 1.51 billion or 1.57 per share.

Cash & Cash Equivalents	2.26B
Total Debt	748.43M
Net Cash	1.51B
Net Cash Per Share	1.57
Equity (Book Value)	10.87B
Book Value Per Share	11.33
Working Capital	4.02B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.22 billion and capital expenditures -689.14 million, giving a free cash flow of 534.15 million.

Operating Cash Flow	1.22B
Capital Expenditures	-689.14M
Free Cash Flow	534.15M
FCF Per Share	0.56

Full Cash Flow Statement

Margins

Gross margin is 42.33%, with operating and profit margins of 16.09% and 12.38%.

Gross Margin	42.33%
Operating Margin	16.09%
Pretax Margin	12.93%
Profit Margin	12.38%
EBITDA Margin	23.79%
EBIT Margin	16.09%
FCF Margin	5.70%

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 1.11%.

Dividend Per Share	0.15
Dividend Yield	1.11%
Dividend Growth (YoY)	-11.76%
Years of Dividend Growth	n/a
Payout Ratio	14.68%
Buyback Yield	-0.46%
Shareholder Yield	0.64%
Earnings Yield	8.77%
FCF Yield	4.04%

Dividend Details

Stock Splits

The last stock split was on October 9, 2013. It was a forward split with a ratio of 1.8.

Last Split Date	Oct 9, 2013
Split Type	Forward
Split Ratio	1.8

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a